These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

481 related items for PubMed ID: 26776568

  • 1. Effect of olfactory impairment and white matter hyperintensities on cognition in Parkinson's disease.
    Ham JH, Lee JJ, Sunwoo MK, Hong JY, Sohn YH, Lee PH.
    Parkinsonism Relat Disord; 2016 Mar; 24():95-9. PubMed ID: 26776568
    [Abstract] [Full Text] [Related]

  • 2. The burden of white matter hyperintensities is a predictor of progressive mild cognitive impairment in patients with Parkinson's disease.
    Sunwoo MK, Jeon S, Ham JH, Hong JY, Lee JE, Lee JM, Sohn YH, Lee PH.
    Eur J Neurol; 2014 Jun; 21(6):922-e50. PubMed ID: 24661277
    [Abstract] [Full Text] [Related]

  • 3. Topography of cortical thinning associated with white matter hyperintensities in Parkinson's disease.
    Ham JH, Yun HJ, Sunwoo MK, Hong JY, Lee JM, Sohn YH, Lee PH.
    Parkinsonism Relat Disord; 2015 Apr; 21(4):372-7. PubMed ID: 25697488
    [Abstract] [Full Text] [Related]

  • 4. White Matter Hyperintensities and Mild Cognitive Impairment in Parkinson's Disease.
    Mak E, Dwyer MG, Ramasamy DP, Au WL, Tan LC, Zivadinov R, Kandiah N.
    J Neuroimaging; 2015 Apr; 25(5):754-60. PubMed ID: 25753576
    [Abstract] [Full Text] [Related]

  • 5. Modifiable vascular risk factors, white matter disease and cognition in early Parkinson's disease.
    Chahine LM, Dos Santos C, Fullard M, Scordia C, Weintraub D, Erus G, Rosenthal L, Davatzikos C, McMillan CT.
    Eur J Neurol; 2019 Feb; 26(2):246-e18. PubMed ID: 30169897
    [Abstract] [Full Text] [Related]

  • 6. Influence of diabetes mellitus on longitudinal atrophy and cognition in Parkinson's disease.
    Ong M, Foo H, Chander RJ, Wen MC, Au WL, Sitoh YY, Tan L, Kandiah N.
    J Neurol Sci; 2017 Jun 15; 377():122-126. PubMed ID: 28477681
    [Abstract] [Full Text] [Related]

  • 7. White Matter Hyperintensities in Mild Cognitive Impairment and Lower Risk of Cognitive Decline.
    Nolze-Charron G, Mouiha A, Duchesne S, Bocti C, Alzheimer's Disease Neuroimaging Initiative1.
    J Alzheimers Dis; 2015 Jun 15; 46(4):855-62. PubMed ID: 26402625
    [Abstract] [Full Text] [Related]

  • 8. Subcortical white matter hyperintensities within the cholinergic pathways of Parkinson's disease patients according to cognitive status.
    Shin J, Choi S, Lee JE, Lee HS, Sohn YH, Lee PH.
    J Neurol Neurosurg Psychiatry; 2012 Mar 15; 83(3):315-21. PubMed ID: 22228726
    [Abstract] [Full Text] [Related]

  • 9. Cross-sectional and longitudinal associations between total and regional white matter hyperintensity volume and cognitive and motor function in Parkinson's disease.
    Pozorski V, Oh JM, Okonkwo O, Krislov S, Barzgari A, Theisen F, Sojkova J, Bendlin BB, Johnson SC, Gallagher CL.
    Neuroimage Clin; 2019 Mar 15; 23():101870. PubMed ID: 31150958
    [Abstract] [Full Text] [Related]

  • 10. Cerebral white matter hyperintensity in Parkinson's disease: a major risk factor for mild cognitive impairment.
    Kandiah N, Mak E, Ng A, Huang S, Au WL, Sitoh YY, Tan LC.
    Parkinsonism Relat Disord; 2013 Jul 15; 19(7):680-3. PubMed ID: 23623194
    [Abstract] [Full Text] [Related]

  • 11. White matter hyperintensities are not associated with cognitive decline in early Parkinson's disease - The DeNoPa cohort.
    Hanning U, Teuber A, Lang E, Trenkwalder C, Mollenhauer B, Minnerup H.
    Parkinsonism Relat Disord; 2019 Dec 15; 69():61-67. PubMed ID: 31678722
    [Abstract] [Full Text] [Related]

  • 12. Olfactory deficits and cognitive dysfunction in Parkinson's disease.
    Parrao T, Chana P, Venegas P, Behrens MI, Aylwin ML.
    Neurodegener Dis; 2012 Dec 15; 10(1-4):179-82. PubMed ID: 22343138
    [Abstract] [Full Text] [Related]

  • 13. Periventricular white matter hyperintensity burden and cognitive impairment in early Parkinson's disease.
    Huang X, Wen MC, Ng SY, Hartono S, Chia NS, Choi X, Tay KY, Au WL, Chan LL, Tan EK, Tan LC.
    Eur J Neurol; 2020 Jun 15; 27(6):959-966. PubMed ID: 32124496
    [Abstract] [Full Text] [Related]

  • 14. White matter hyperintensities do not impact cognitive function in patients with newly diagnosed Parkinson's disease.
    Dalaker TO, Larsen JP, Dwyer MG, Aarsland D, Beyer MK, Alves G, Bronnick K, Tysnes OB, Zivadinov R.
    Neuroimage; 2009 Oct 01; 47(4):2083-9. PubMed ID: 19539037
    [Abstract] [Full Text] [Related]

  • 15. Excessive variability in systolic blood pressure that is self-measured at home exacerbates the progression of brain white matter lesions and cognitive impairment in the oldest old.
    Liu Z, Zhao Y, Zhang H, Chai Q, Cui Y, Diao Y, Xiu J, Sun X, Jiang G.
    Hypertens Res; 2016 Apr 01; 39(4):245-53. PubMed ID: 26631851
    [Abstract] [Full Text] [Related]

  • 16. Executive dysfunction assessed by Clock-Drawing Test in older non-demented subjects with metabolic syndrome is not mediated by white matter lesions.
    Viscogliosi G, Chiriac IM, Andreozzi P, Ettorre E.
    Psychiatry Clin Neurosci; 2015 Oct 01; 69(10):620-9. PubMed ID: 25781474
    [Abstract] [Full Text] [Related]

  • 17. Microstructural Connectivity is More Related to Cognition than Conventional MRI in Parkinson's Disease.
    Lee YH, Lee WJ, Chung SJ, Yoo HS, Jung JH, Baik K, Sohn YH, Seong JK, Lee PH.
    J Parkinsons Dis; 2021 Oct 01; 11(1):239-249. PubMed ID: 33074193
    [Abstract] [Full Text] [Related]

  • 18. The combined effect of REM sleep behavior disorder and hyposmia on cognition and motor phenotype in Parkinson's disease.
    Kang SH, Lee HM, Seo WK, Kim JH, Koh SB.
    J Neurol Sci; 2016 Sep 15; 368():374-8. PubMed ID: 27538667
    [Abstract] [Full Text] [Related]

  • 19. Effects of medial temporal atrophy and white matter hyperintensities on the cognitive functions in patients with Alzheimer's disease.
    Shim YS, Youn YC, Na DL, Kim SY, Cheong HK, Moon SY, Park KW, Ku BD, Lee JY, Jeong JH, Kang H, Kim EJ, Lee JS, Go SM, Kim SH, Cha KR, Seo SW.
    Eur Neurol; 2011 Sep 15; 66(2):75-82. PubMed ID: 21778730
    [Abstract] [Full Text] [Related]

  • 20. Impaired cholinergic transmission in patients with Parkinson's disease and olfactory dysfunction.
    Versace V, Langthaler PB, Sebastianelli L, Höller Y, Brigo F, Orioli A, Saltuari L, Nardone R.
    J Neurol Sci; 2017 Jun 15; 377():55-61. PubMed ID: 28477708
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.